NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 6 percent increase in fiscal fourth quarter revenues and a 2 percent increase in fiscal year 2017 revenues.
For the quarter ended Sept. 30, the diagnostics manufacturer reported revenue of $49.7 million compared to $47.0 million in the prior year, above analysts' consensus estimate of $48.1 million and slightly above preliminary earnings announced last month of $49.5 million.